These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 15480415)

  • 1. Protein kinase A isozyme switching: eliciting differential cAMP signaling and tumor reversion.
    Neary CL; Nesterova M; Cho YS; Cheadle C; Becker KG; Cho-Chung YS
    Oncogene; 2004 Nov; 23(54):8847-56. PubMed ID: 15480415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Compensatory stabilization of RIIbeta protein, cell cycle deregulation, and growth arrest in colon and prostate carcinoma cells by antisense-directed down-regulation of protein kinase A RIalpha protein.
    Nesterova M; Noguchi K; Park YG; Lee YN; Cho-Chung YS
    Clin Cancer Res; 2000 Sep; 6(9):3434-41. PubMed ID: 10999726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein kinase A RIalpha antisense inhibition of PC3M prostate cancer cell growth: Bcl-2 hyperphosphorylation, Bax up-regulation, and Bad-hypophosphorylation.
    Cho YS; Kim MK; Tan L; Srivastava R; Agrawal S; Cho-Chung YS
    Clin Cancer Res; 2002 Feb; 8(2):607-14. PubMed ID: 11839683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemoprevention with protein kinase A RIalpha antisense in DMBA-mammary carcinogenesis.
    Nesterova MV; Cho-Chung YS
    Ann N Y Acad Sci; 2005 Nov; 1058():255-64. PubMed ID: 16394142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antisense protein kinase A RIalpha inhibits 7,12-dimethylbenz(a)anthracene-induction of mammary cancer: blockade at the initial phase of carcinogenesis.
    Nesterova MV; Cho-Chung YS
    Clin Cancer Res; 2004 Jul; 10(13):4568-77. PubMed ID: 15240549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nuclear translocation of the catalytic subunit of protein kinase A induced by an antisense oligonucleotide directed against the RIalpha regulatory subunit.
    Neary CL; Cho-Chung YS
    Oncogene; 2001 Nov; 20(55):8019-24. PubMed ID: 11753685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isozymes of cyclic AMP-dependent protein kinases (PKA) in human lymphoid cell lines: levels of endogenous cAMP influence levels of PKA subunits and growth in lymphoid cell lines.
    Skålhegg BS; Johansen AK; Levy FO; Andersson KB; Aandahl EM; Blomhoff HK; Hansson V; Taskén K
    J Cell Physiol; 1998 Oct; 177(1):85-93. PubMed ID: 9731748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor reversion: protein kinase A isozyme switching.
    Cho-Chung YS; Nesterova MV
    Ann N Y Acad Sci; 2005 Nov; 1058():76-86. PubMed ID: 16394127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Participation of type II protein kinase A in the retinoic acid-induced growth inhibition of SH-SY5Y human neuroblastoma cells.
    Kim SN; Kim SG; Park SD; Cho-Chung YS; Hong SH
    J Cell Physiol; 2000 Mar; 182(3):421-8. PubMed ID: 10653609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extracellular catalytic subunit activity of the cAMP-dependent protein kinase in prostate cancer.
    Cvijic ME; Kita T; Shih W; DiPaola RS; Chin KV
    Clin Cancer Res; 2000 Jun; 6(6):2309-17. PubMed ID: 10873081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The p85 regulatory subunit of PI3K mediates TSH-cAMP-PKA growth and survival signals.
    De Gregorio G; Coppa A; Cosentino C; Ucci S; Messina S; Nicolussi A; D'Inzeo S; Di Pardo A; Avvedimento EV; Porcellini A
    Oncogene; 2007 Mar; 26(14):2039-47. PubMed ID: 17043656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mapping intersubunit interactions of the regulatory subunit (RIalpha) in the type I holoenzyme of protein kinase A by amide hydrogen/deuterium exchange mass spectrometry (DXMS).
    Hamuro Y; Anand GS; Kim JS; Juliano C; Stranz DD; Taylor SS; Woods VL
    J Mol Biol; 2004 Jul; 340(5):1185-96. PubMed ID: 15236976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclic AMP-dependent protein kinase type I is involved in hypersensitivity of human breast cells to topoisomerase II inhibitors.
    Tortora G; Ciardiello F; Damiano V; Pepe S; Bianco C; di Isernia G; Davies SL; North P; Harris AL; Hickson ID
    Clin Cancer Res; 1995 Jan; 1(1):49-56. PubMed ID: 9815886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel, isotype-specific sensors for protein kinase A subunit interaction based on bioluminescence resonance energy transfer (BRET).
    Prinz A; Diskar M; Erlbruch A; Herberg FW
    Cell Signal; 2006 Oct; 18(10):1616-25. PubMed ID: 16524697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential localization of protein kinase A type II isozymes in the Golgi-centrosomal area.
    Keryer G; Skålhegg BS; Landmark BF; Hansson V; Jahnsen T; Taskén K
    Exp Cell Res; 1999 May; 249(1):131-46. PubMed ID: 10328961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crystal structures of RIalpha subunit of cyclic adenosine 5'-monophosphate (cAMP)-dependent protein kinase complexed with (Rp)-adenosine 3',5'-cyclic monophosphothioate and (Sp)-adenosine 3',5'-cyclic monophosphothioate, the phosphothioate analogues of cAMP.
    Wu J; Jones JM; Nguyen-Huu X; Ten Eyck LF; Taylor SS
    Biochemistry; 2004 Jun; 43(21):6620-9. PubMed ID: 15157095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CpG immunomer DNA enhances antisense protein kinase A RIalpha inhibition of multidrug-resistant colon carcinoma growth in nude mice: molecular basis for combinatorial therapy.
    Nesterova MV; Johnson NR; Stewart T; Abrams S; Cho-Chung YS
    Clin Cancer Res; 2005 Aug; 11(16):5950-5. PubMed ID: 16115938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical characterization of extracellular cAMP-dependent protein kinase as a tumor marker.
    Cho YS; Lee YN; Cho-Chung YS
    Biochem Biophys Res Commun; 2000 Nov; 278(3):679-84. PubMed ID: 11095968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effects of substrate on type I and type II PKA holoenzyme dissociation.
    Vigil D; Blumenthal DK; Brown S; Taylor SS; Trewhella J
    Biochemistry; 2004 May; 43(19):5629-36. PubMed ID: 15134437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conformational differences among solution structures of the type Ialpha, IIalpha and IIbeta protein kinase A regulatory subunit homodimers: role of the linker regions.
    Vigil D; Blumenthal DK; Heller WT; Brown S; Canaves JM; Taylor SS; Trewhella J
    J Mol Biol; 2004 Apr; 337(5):1183-94. PubMed ID: 15046986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.